Diabetes, depression, and quality of life - A population study

被引:403
作者
Goldney, RD [1 ]
Phillips, PJ [1 ]
Fisher, LJ [1 ]
Wilson, DH [1 ]
机构
[1] Univ Adelaide, Dept Psychiat, Adelaide Clin, Gilberton, SA 5081, Australia
关键词
D O I
10.2337/diacare.27.5.1066
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - The aim of the study was to assess the prevalence of diabetes and depression and their associations with quality of life using a representative population sample. RESEARCH DESIGN AND METHODS - The study consisted of a representative population sample of individuals aged 15 years living in South Australia comprising 3,010 personal interviews conducted by trained health interviewers. The prevalence of depression in those suffering doctor-diagnosed diabetes and comparative effects of diabetic status and depression on quality-of-life dimensions were measured. RESULTS - The prevalence of depression in the diabetic population was 24% compared with 17% in the nondiabetic population. Those with diabetes and depression experienced an impact with a large effect size on every dimension of the Short Form Health-Related Quality-of-Life Questionnaire (SF-36) as compared with those who suffered diabetes and who were not depressed. A supplementary analysis comparing both depressed diabetic and depressed nondiabetic groups showed there were statistically significant differences in the quality-of-life effects between the two depressed populations in the physical and mental component summaries of the SF-36. CONCLUSIONS - Depression for those With diabetes is an important comorbidity that requires careful management because Of its severe impact on quality of life.
引用
收藏
页码:1066 / 1070
页数:5
相关论文
共 27 条
[11]   Prevalence and costs of major depression among elderly claimants with diabetes [J].
Finkelstein, EA ;
Bray, JW ;
Chen, H ;
Larson, MJ ;
Miller, K ;
Tompkins, C ;
Keme, A ;
Manderscheid, R .
DIABETES CARE, 2003, 26 (02) :415-420
[12]   THE SF-36 HEALTH SURVEY QUESTIONNAIRE - AN OUTCOME MEASURE SUITABLE FOR ROUTINE USE WITHIN THE NHS [J].
GARRATT, AM ;
RUTA, DA ;
ABDALLA, MI ;
BUCKINGHAM, JK ;
RUSSELL, IT .
BMJ-BRITISH MEDICAL JOURNAL, 1993, 306 (6890) :1440-1444
[13]   Depressive symptoms and metabolic control in African-Americans with type 2 diabetes [J].
Gary, TL ;
Ford, D ;
Crum, RM ;
Brancati, FL ;
Cooper-Patrick, L .
DIABETES CARE, 2000, 23 (01) :23-29
[14]   PREVALENCE OF DEPRESSION IN ADULTS WITH DIABETES - AN EPIDEMIOLOGIC EVALUATION [J].
GAVARD, JA ;
LUSTMAN, PJ ;
CLOUSE, RE .
DIABETES CARE, 1993, 16 (08) :1167-1178
[15]  
Goodnick P J, 2000, Expert Opin Pharmacother, V1, P1367, DOI 10.1517/14656566.1.7.1367
[16]  
Hosmer D. W., 1989, APPL LOGISTIC REGRES, DOI DOI 10.1097/00019514-200604000-00003
[17]   EFFECT SIZES FOR INTERPRETING CHANGES IN HEALTH-STATUS [J].
KAZIS, LE ;
ANDERSON, JJ ;
MEENAN, RF .
MEDICAL CARE, 1989, 27 (03) :S178-S189
[18]   Depression and immune function - Central pathways to morbidity and mortality [J].
Kiecolt-Glaser, JK ;
Glaser, R .
JOURNAL OF PSYCHOSOMATIC RESEARCH, 2002, 53 (04) :873-876
[19]   Treatment of depression in diabetes - Impact on mood and medical outcome [J].
Lustman, PJ ;
Clouse, RE .
JOURNAL OF PSYCHOSOMATIC RESEARCH, 2002, 53 (04) :917-924
[20]   Depression and poor glycemic control - A meta-analytic review of the literature [J].
Lustman, PJ ;
Anderson, RJ ;
Freedland, KE ;
de Groot, M ;
Carney, RM ;
Clouse, RE .
DIABETES CARE, 2000, 23 (07) :934-942